Bymetric
UK company intelligence
Company Active LTD

Company profile

Testavec Limited

UK company 10844271, incorporated on 30 June 2017.

Home | Testavec

Testavec Limited is a UK company with status Active founded in 2017 based in South East England.

Company number
10844271
Incorporated
30 Jun 2017
Companies House status
Active

Company identity

Founded / incorporated
30 June 2017

Company number 10844271

Verify at Companies House
Legal name
TESTAVEC LIMITED
Company type
Private Limited Company
Region
South East England
Registered address
QUEENSGATE HOUSE
18 COOKHAM ROAD
MAIDENHEAD
ENGLAND
SL6 8BD
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Apr
2027

Accounts due

Accounts Due

Next accounts due date

04 Aug
2026

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzUzNzAwOTk5N2FkaXF6a2N4

Published 04 Aug 2026 15:09

02 Aug
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Jul
2025

Accounts filed

Accounts

Last accounts made up date

19 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Jun
2017

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2018
Funded years
2018
Age at first award
0 years

Projects

2018 Feasibility Studies Lead participant

Establishment of a human iPS cell based cardiac gene therapv safety model

1 Jan 2018 to 31 Dec 2018

Awarded
£102,588
Total cost £146,554

Gene therapy (GT) has reached the clinic with substantial investment by pharmaceutical companies that include GSK, Novartis, Astra Zenica and Pfizer. Applications for clinical trials are increasing and virus based products such as ‘Stremvellis’ by GSK and ‘Glybera’ by Uniqure have been granted. In the past, GT has met with set-backs in trials in France an...

Product types

Feasibility Studies